Effect of Tadalafil on prostate haemodynamics: preliminary evaluation with contrast-enhanced US.
about
Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of actionTadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: analyses of data pooled from three randomized, double-blind, placebo-controlled studies.A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunctionMirodenafil prevents bladder dysfunction induced by chronic bladder ischemia in rats.New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectivesPathogenic mechanisms linking benign prostatic hyperplasia, lower urinary tract symptoms and erectile dysfunctionContrast-Enhanced Ultrasonography with Quantitative Analysis allows Differentiation of Renal Tumor Histotypes.Emerging drugs for the treatment of benign prostatic obstruction.Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action.Daily phosphodiesterase type 5 inhibitor therapy: a new treatment option for prostatitis/prostatodynia?Tadalafil in the management of lower urinary tract symptoms: a review of the literature and current practices in Russia.Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.RETRACTED: Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia.Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.[Medicinal therapy of benign prostate syndrome with phosphodiesterase-5 inhibitors].
P2860
Q26783529-5AB48BFB-691A-4C91-9BBF-66C410F3F7A9Q30899027-6131FB8A-3934-46DE-8E05-A4EB2C64635DQ33744285-AAD70010-DBEB-479A-AE28-A9031C59356CQ35281132-561CC39F-47AD-4609-89B3-C9AAF3DC9BEBQ36133212-41EC4706-31F4-4603-B18C-6A89E0C822E6Q37040760-3F59B000-FF84-4A0F-994D-8CD964CC4F04Q37325382-25FA4794-5C1E-4648-A145-A3C2FCE5200DQ37743490-9F6A1C02-A98F-4C7C-8968-3BDE3C34E747Q37833959-C7749A11-4973-42C9-AFD1-7CB88DCCAB3EQ38216037-566E7529-5E28-4A9B-9FC9-686771A01271Q38241547-70EF80FA-D37F-4843-9D42-EA93ED1F9EAAQ39195242-5D232692-6148-45D5-AA70-DDCF9DB3FEDFQ41988384-7D5B10CB-BA25-43F5-B1A3-CFC94801EBE5Q43521565-3919E780-760D-411D-9385-7D97A8DA60E1Q43785753-5C9461D2-C029-4089-AB51-FAD0D5E778E9
P2860
Effect of Tadalafil on prostate haemodynamics: preliminary evaluation with contrast-enhanced US.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Effect of Tadalafil on prostat ...... ion with contrast-enhanced US.
@en
Effect of Tadalafil on prostat ...... ion with contrast-enhanced US.
@nl
type
label
Effect of Tadalafil on prostat ...... ion with contrast-enhanced US.
@en
Effect of Tadalafil on prostat ...... ion with contrast-enhanced US.
@nl
prefLabel
Effect of Tadalafil on prostat ...... ion with contrast-enhanced US.
@en
Effect of Tadalafil on prostat ...... ion with contrast-enhanced US.
@nl
P2093
P1476
Effect of Tadalafil on prostat ...... tion with contrast-enhanced US
@en
P2093
P2860
P2888
P304
P356
10.1007/S11547-009-0449-8
P577
2009-08-20T00:00:00Z